The Leadership Development for Researchers (LEADER) Program is designed for junior faculty who are leading a research group and driving their own research agenda.

The National Institute of Allergy and Infectious Diseases awarded researchers at the Duke Human Vaccine Institute a contract that enables it to compete for projects advancing investigational vaccines to production for use in early clinical trials.

With numerous recent studies demonstrating that antibiotics work as well as surgery for most uncomplicated appendicitis cases, the non-surgical approach can now be considered a routine option, according to a review article in JAMA

A STAT News investigation into Orthopaedic Surgery, deeming it "the whitest specialty."

Duke launches an ambitious new effort to elevate and sustain excellence in science and technology.

The work of research team that includes Dr. David Montefiori of the Duke Human Vaccine Institute is highlighted in the NIH Director's Blog.

The human placenta performs a delicate balancing act: it must let beneficial nutrients pass from the mother to the developing fetus, but block harmful pathogens from making the same trip. Carolyn Coyne, PhD, investigates how the placenta has evolved to be such a fantastic protector but can also be vulnerable to pathogens.

When certain immune cells in our bodies are invaded by a dangerous pathogen, they sacrifice themselves to vanquish the intruders.

Humans are born with all the nerve cells they will ever have, and in each of those nerve cells live about two million mitochondria. As mitochondria age or become dysfunctional, the cell systematically removes them and replaces them with newer models. Neurobiologist Chantell Evans, PhD, wants to know more about this complex process.

Think of the inner circuitry of the brain as a traffic network. When nerve cells release a signal, the information speeds along various routes to its destination: another nerve cell elsewhere in the brain. Neurobiologist Josh Huang, PhD, is especially interested in a particular type of inhibitory nerve cells called chandelier cells.